AR038380A1 - 2 ' -halo-3 ' , 5 ' -dialcoxi-fen-1' -il-imino-2-imidazolidinas y su uso como un farmaco - Google Patents

2 ' -halo-3 ' , 5 ' -dialcoxi-fen-1' -il-imino-2-imidazolidinas y su uso como un farmaco

Info

Publication number
AR038380A1
AR038380A1 ARP030100289A ARP030100289A AR038380A1 AR 038380 A1 AR038380 A1 AR 038380A1 AR P030100289 A ARP030100289 A AR P030100289A AR P030100289 A ARP030100289 A AR P030100289A AR 038380 A1 AR038380 A1 AR 038380A1
Authority
AR
Argentina
Prior art keywords
imidazolidinas
dialcoxi
pharmaco
fen
imino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
ARP030100289A
Other languages
English (en)
Inventor
Esser Franz Dr
Pouzet Pascale Dr
Naoki Ishiguro
Kitagawa Hisato Dr
Muramatsu Ikunobu Prof
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH Co KG filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of AR038380A1 publication Critical patent/AR038380A1/es
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Abstract

Reivindicación 1: Un compuesto de acuerdo con la fórmula (1) en la que R es F, Cl, Br, CF3, CH2F o CHF2 y R1 y R2 independientemente uno de otro, pueden ser cualquier alquilo de C1 a C6, su forma tautómera de acuerdo con la fórmula general (2) o una sal farmacológicamente aceptable del mismo.
ARP030100289A 2002-01-31 2003-01-31 2 ' -halo-3 ' , 5 ' -dialcoxi-fen-1' -il-imino-2-imidazolidinas y su uso como un farmaco Withdrawn AR038380A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02002352A EP1333028A1 (en) 2002-01-31 2002-01-31 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence

Publications (1)

Publication Number Publication Date
AR038380A1 true AR038380A1 (es) 2005-01-12

Family

ID=8185397

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100289A Withdrawn AR038380A1 (es) 2002-01-31 2003-01-31 2 ' -halo-3 ' , 5 ' -dialcoxi-fen-1' -il-imino-2-imidazolidinas y su uso como un farmaco

Country Status (20)

Country Link
EP (2) EP1333028A1 (es)
JP (1) JP2005516066A (es)
KR (1) KR20040074134A (es)
CN (1) CN1617857A (es)
AR (1) AR038380A1 (es)
BR (1) BR0215560A (es)
CA (1) CA2474588A1 (es)
EA (1) EA200400877A1 (es)
EC (1) ECSP045210A (es)
HR (1) HRP20040691A2 (es)
HU (1) HUP0402654A2 (es)
IL (1) IL162776A0 (es)
MX (1) MXPA04007250A (es)
NO (1) NO20043614L (es)
PE (1) PE20030819A1 (es)
PL (1) PL369826A1 (es)
TW (1) TW200418462A (es)
UY (1) UY27628A1 (es)
WO (1) WO2003064398A1 (es)
ZA (1) ZA200405173B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体
US20090286829A1 (en) * 2008-05-13 2009-11-19 Allergan, Inc. Quinolynylmethylimidizoles as therapeutic agents
US8258167B2 (en) 2008-05-13 2012-09-04 Allergan, Inc Naphthylmethylimidizoles as therapeutic agents
US8063231B2 (en) * 2008-06-09 2011-11-22 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions
EP2303264B1 (en) * 2008-06-09 2018-04-04 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions using imidazoline derivatives
US9034910B2 (en) 2008-06-09 2015-05-19 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2220906A1 (de) * 1972-04-28 1973-11-15 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2259160A1 (de) * 1972-12-02 1974-06-06 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline, deren saeureadditionssalze und verfahren zur herstellung derselben sowie ihre verwendung als arzneimittel
AT333749B (de) * 1974-07-03 1976-12-10 Chemie Linz Ag Verfahren zur herstellung von neuen 2-arylamino-2-imidazolinderivaten
MTP837B (en) * 1977-11-07 1979-10-22 Hoffman La Roche And Co Aktien Derivatives 2 finino-imidazolidire
DE3514351A1 (de) * 1985-04-20 1986-11-06 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte 2-(n-alkinyl-n-phenyl)amino)-imidazolinderivate, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
DE19740176C2 (de) * 1997-09-12 2000-04-06 Lemfoerder Metallwaren Ag Handschaltvorrichtung für ein Kraftfahrzeug

Also Published As

Publication number Publication date
IL162776A0 (en) 2005-11-20
EP1472231A1 (en) 2004-11-03
PL369826A1 (en) 2005-05-02
KR20040074134A (ko) 2004-08-21
JP2005516066A (ja) 2005-06-02
NO20043614L (no) 2004-08-30
EP1333028A1 (en) 2003-08-06
CA2474588A1 (en) 2003-08-07
ZA200405173B (en) 2005-06-21
BR0215560A (pt) 2004-12-21
EA200400877A1 (ru) 2005-02-24
HRP20040691A2 (en) 2004-12-31
TW200418462A (en) 2004-10-01
UY27628A1 (es) 2003-08-29
ECSP045210A (es) 2004-09-28
CN1617857A (zh) 2005-05-18
HUP0402654A2 (hu) 2005-03-29
MXPA04007250A (es) 2004-10-29
WO2003064398A1 (en) 2003-08-07
PE20030819A1 (es) 2003-10-20

Similar Documents

Publication Publication Date Title
AR049274A1 (es) Acido2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-(fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor selectivo de la quinasa ikk-2
CY1111481T1 (el) Υποκατεστημενα αρυλοκυκλοπροπυλακεταμιδια ως ενεργοποιητες γλυκοκινασης
EA200100757A1 (ru) Хинолинкарбоксамиды в качестве противовирусных агентов
NO20034291D0 (no) 2-aminopropanolderivater
EA200500017A1 (ru) Новые соединения
AR047076A1 (es) Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas
ATE427926T1 (de) Cycloalkylaminderivate
MY138941A (en) Aryl-pyridine derivatives
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
ATE292634T1 (de) Inhibitoren der alpha-l beta-2 vermittelten zelladhäsion
AR061134A1 (es) Derivados de tioxantina
RS50574B (sr) (4-metoksi-7-morfolin-4-il-benzotiazol-2-il)-amid 4-hidroksi-4-metil-piperidin-1-karboksilne kiseline
DE60015390D1 (de) Antidiabetische thiazolidindione und ihre herstellung
AR038380A1 (es) 2 ' -halo-3 ' , 5 ' -dialcoxi-fen-1' -il-imino-2-imidazolidinas y su uso como un farmaco
ES2117264T3 (es) Nuevo compuesto con actividad inhibitoria de la agregacion plaquetaria.
ATE408610T1 (de) Alkyl-und piperidin-substitutierte benzimidazol- derivate
EA200700179A1 (ru) Производные пиррола, их получение и их применение в терапии
MA27143A1 (fr) Utilisation de derives de 2-amino-4- pyridylmethyl-thiazoline comme inhibiteurs de no-synthase inductible
ID30435A (id) Proses-proses untuk menyiapkan perantara-perantara pestisidal
GB0130868D0 (en) New compounds
ATE348800T1 (de) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
DE60017374D1 (de) Antibakterielle mittel
EA200201023A1 (ru) Ингибитор натрий-водородного обмена типа 1(nhe-1)
AR042674A1 (es) [4-( 3-aminometilfenil) piperidin-1-il] - [5-(2-fluorofeniletinil) furan-2-il] -metanona como un inhibidor de triptasa de celulas mast
ECSP045086A (es) Composiciones farmaceuticas que contienen macrolidos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal